1302 — LifeTech Scientific Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for LifeTech Scientific, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	243	333	378	176	199
Depreciation
Amortisation
Non-Cash Items	16.2	-3.9	86.1	272	146
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	22.7	55.7	-136	-98.3	-103
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	339	441	388	418	321
Capital Expenditures	-105	-276	-226	-206	-205
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-237	237	-232	-248	-312
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-342	-39	-458	-454	-518
Financing Cash Flow Items	-10.2	14.7	0.158	10.8	36.2
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	675	-256	-215	183	-117
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	673	148	-285	146	-314